KEGG: pdi:BDI_2407
STRING: 435591.BDI_2407
Parabacteroides distasonis is a Gram-negative, rod-shaped, obligatory anaerobic bacterium that was first isolated from human feces in 1933. It serves as the reference type strain for the genus Parabacteroides and is a commensal bacterium in the gastrointestinal tract of humans and animals . P. distasonis has demonstrated ambivalent roles, exhibiting both pathogenic and probiotic properties. Recent research indicates it plays protective roles against multiple sclerosis, diabetes, cancer, and Crohn's disease, while also potentially contributing to antimicrobial resistance and other clinical developments .
A single P. distasonis ATCC 8503 cell measures 0.8–1.6 × 1.2–12 μm in size. When cultured on sheep blood agar plates, it forms colonies that are 1–2 mm in diameter, appearing gray to off-white with circular, slightly convex, and smooth morphology .
Undecaprenyl-diphosphatase (uppP), also known as Bacitracin resistance protein or Undecaprenyl pyrophosphate phosphatase, is an integral membrane protein involved in bacterial cell wall synthesis . It catalyzes the critical dephosphorylation of undecaprenyl pyrophosphate to undecaprenyl phosphate, which serves as an essential carrier lipid in the bacterial cell wall synthesis pathway . This enzymatic activity is fundamental to bacterial cell wall integrity and function.
P. distasonis exhibits distinct chemo-taxonomic features that differentiate it from related species. The ratios of anteiso-C15:0 to iso-C15:0 range from 3.1 to 10.3 in P. distasonis strains, while those for T. forsythensis range from 22.8 to 95.2. Major menaquinones of P. distasonis are MK-9 and MK-10, while Bacteroides species typically contain MK-10 and MK-11 . These biochemical differences were significant enough to prompt researchers to place P. distasonis in its own genus, named Parabacteroides, meaning "adjacent to Bacteroides."
Computational modeling, molecular dynamics, and mutagenesis studies have proposed that the enzyme active site is composed of two key consensus motifs: (E/Q)XXXE and PGXSRSXXT, along with a histidine residue. This active site is proposed to be located in the periplasm . Sequence alignment has revealed two consensus regions containing glutamate-rich motifs that are critical for enzyme function. Understanding this structure provides insights into the enzyme's catalytic mechanism and potential for inhibitor development.
The enzyme catalyzes the dephosphorylation of undecaprenyl pyrophosphate to form undecaprenyl phosphate. While the exact catalytic mechanism isn't fully detailed in the available research, the identified active site motifs (E/Q)XXXE and PGXSRSXXT along with a histidine residue likely coordinate the binding of the substrate and facilitate the phosphate hydrolysis . This enzymatic activity is essential for bacterial cell wall biosynthesis and represents a potential antibiotic target.
Researchers can measure uppP activity through several approaches, although specific methods aren't detailed in the search results. Typical assays for phosphatase activity include:
Colorimetric detection of released phosphate using molybdate-based reagents
Radiometric assays using labeled substrates
HPLC-based detection of reaction products
Coupled enzyme assays that link phosphate release to detectable signals
These assays would need to be adapted to the membrane-associated nature of the enzyme and its specific substrate requirements.
P. distasonis requires strict anaerobic conditions for cultivation. Based on the literature, researchers typically culture this organism under conditions of 80% H₂, 10% CO₂, 10% N₂ at 35°C for 4 days . Small colonies (1–2 mm) are selected and subcultured under anaerobic conditions at 35°C for 2 days. The bacterium can be definitively identified using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) Biotyper .
The genome of P. distasonis strain GP102 has been completely sequenced and analyzed. Sequencing involved both Illumina short reads (n = 1,487,056) and Nanopore long reads (n = 35,990; N₅₀ = 3,369 bp), which were assembled into one circular contig with 193× depth using Unicycler . The genome consists of one circular chromosome that is 5,387,833 bp in length with a G+C content of 44.79%. When annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP v4.11), the genome was found to contain 4,730 coding genes, 122 pseudo genes, 84 tRNAs, 21 rRNAs, and 1 CRISPR array .
Recombinant P. distasonis uppP can be produced using a baculovirus expression system. This approach has yielded protein with >85% purity as determined by SDS-PAGE . The recombinant protein is derived from P. distasonis strain ATCC 8503, which is also cataloged as DSM 20701, CIP 104284, JCM 5825, and NCTC 11152 . This standardized production system allows for consistent protein quality for research applications.
| Parameter | Specification |
|---|---|
| Expression System | Baculovirus |
| Source Strain | P. distasonis ATCC 8503 |
| Purity | >85% (SDS-PAGE) |
| Reconstitution | Deionized sterile water (0.1-1.0 mg/mL) |
| Recommended Additive | 5-50% glycerol (final concentration) |
| Storage Conditions | -20°C/-80°C |
| Shelf Life (liquid) | 6 months at -20°C/-80°C |
| Shelf Life (lyophilized) | 12 months at -20°C/-80°C |
| Working Storage | 4°C for up to one week |
P. distasonis has been studied in the context of ulcerative colitis, a form of inflammatory bowel disease. Research has established a relationship between the levels of this bacterium and disease relapse patterns. In one study involving 105 ulcerative colitis patients in remission, a predictive model incorporating demographic information, clinical data, and the levels of Akkermansia muciniphila and P. distasonis was developed to understand remission patterns . The findings revealed a negative correlation between the levels of these two microorganisms and the duration of remission, suggesting their potential role as prognostic markers for disease management .
P. distasonis-derived outer membrane vesicles (Pd-OMVs) demonstrate significant potential for colon cancer therapy. Research has shown that Pd-OMVs possess potent immunostimulatory effects and exhibit anti-colon tumor properties . In vitro studies have examined the effects of Pd-OMVs on CT26 cell uptake, proliferation, and invasion, while in vivo studies using a CT26 colon tumor model have investigated the anti-colon tumor effects and underlying mechanisms . These findings highlight the potential of Pd-OMVs as a novel approach to cancer immunotherapy.
The isolation and purification of Pd-OMVs follows a systematic protocol:
P. distasonis (ATCC 8503) is subcultured in BHI broth with 150 × g shaking at 37°C for 48 h under anaerobic conditions
The cultures are centrifuged twice at 10,000 × g for 20 min at 4°C
The supernatant is filtered through a 0.45 μm pore size filter to remove residual bacteria and cellular debris
The cell-free filtrate is ultracentrifuged at 150,000 × g for 2 h at 4°C to obtain the Pd-OMVs precipitates
For purification, the precipitates are resuspended in sterile phosphate-buffered saline (PBS)
The suspension is transferred to ultrafiltration centrifuge tubes (30 kDa) and centrifuged at 8000 × g
This process yields purified Pd-OMVs suitable for experimental studies and potential therapeutic applications.
P. distasonis produces a catalase similar to that of B. fragilis, but notably, the enzyme is twice the size (250,000) . Several variables affect P. distasonis' catalase production, including the type of medium used, the presence of agar, and the addition of hemin either pre- or post-autoclaving. Higher catalase levels are observed after hemin is added post-autoclaving and when the selected medium has a high carbohydrate content . This distinctive catalase property serves as a biochemical marker for identification and differentiation from related species.
| Feature | P. distasonis | Bacteroides species | T. forsythensis |
|---|---|---|---|
| Catalase production | Positive (enzyme size ~250,000) | Variable (B. fragilis: positive; B. uniformis: negative) | Not specified |
| Gelatin hydrolysis | Negative | Variable (B. ovatus: positive) | Not specified |
| Major menaquinones | MK-9 and MK-10 | MK-10 and MK-11 | Not specified |
| Anteiso-C15:0 to iso-C15:0 ratio | 3.1 to 10.3 | Not specified | 22.8 to 95.2 |
Transcriptomic analysis represents a powerful approach to understanding P. distasonis interactions with host systems, particularly in disease contexts. For example, researchers have employed transcriptome analysis of tumor tissues to determine the mechanisms by which Pd-OMVs limit colon tumor growth . This approach allows for comprehensive assessment of gene expression changes in response to bacterial factors, providing insights into the molecular pathways involved in host-microbe interactions.
Key methodological considerations for transcriptomic studies include:
RNA extraction protocols optimized for both bacterial and host tissue samples
RNA-seq library preparation with appropriate controls
Bioinformatic pipelines for differential expression analysis
Pathway enrichment and gene ontology analyses
Validation of key findings with RT-qPCR or protein-level studies
Several challenges exist in studying the structure-function relationship of uppP enzymes:
As integral membrane proteins, uppP enzymes present difficulties in crystallization for structural determination
The hydrophobic nature of the enzymes and their substrates complicates in vitro biochemical assays
The essential nature of these enzymes in bacterial survival makes genetic manipulation challenging
Limited availability of specific inhibitors hampers functional studies
The dynamic nature of enzyme-substrate interactions requires sophisticated biophysical techniques
Despite these challenges, approaches such as computer modeling, molecular dynamics simulations, and site-directed mutagenesis have provided valuable insights into the enzyme's active site and catalytic mechanism .
Given the essential role of uppP in bacterial cell wall synthesis, this enzyme represents a potential target for novel antimicrobial development. Inhibitors specifically designed against P. distasonis uppP could potentially disrupt bacterial cell wall synthesis. Additionally, the understanding of bacitracin resistance mechanisms mediated by uppP could inform strategies to overcome antimicrobial resistance. Further structural and functional characterization of the enzyme will be crucial for rational drug design efforts.
The ambivalent role of P. distasonis in health and disease suggests significant potential for microbiome-based therapeutic approaches. The probiotic properties of P. distasonis, particularly its protective effects against multiple sclerosis, diabetes, cancer, and Crohn's disease , warrant further investigation for therapeutic applications. The development of P. distasonis-based probiotics or postbiotics could offer novel strategies for managing these conditions. The anti-colon tumor properties of Pd-OMVs also present promising avenues for cancer immunotherapy development.
Integrated genomic and proteomic approaches offer powerful tools for advancing our understanding of P. distasonis functionality. Comparative genomic analyses across different strains can identify core and accessory genes that contribute to the bacterium's diverse roles in health and disease. Proteomic profiling can reveal the expression patterns of key enzymes like uppP under different conditions, providing insights into regulatory mechanisms. These approaches, combined with metabolomic analyses, can elucidate the functional pathways that underlie P. distasonis' interactions with the host and other microbiota.